ProQR Therapeutics (PRQR) Dividends Paid - Common Growth (5y) (2018 - 2025)
ProQR Therapeutics (PRQR) Dividends Paid - Common Growth (5y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3.78% |
| Mar 31, 2025 | 318.69% |
| Sep 30, 2024 | 3.36% |
| Jun 30, 2024 | -1.70% |
| Mar 31, 2024 | -2.73% |
| Sep 30, 2023 | -0.16% |
| Jun 30, 2023 | 28.90% |
| Mar 31, 2023 | 1,899.43% |
| Sep 30, 2022 | 1,750.24% |
| Jun 30, 2022 | 29.10% |
| Mar 31, 2022 | 408.16% |
| Dec 31, 2021 | 27.43% |
| Sep 30, 2021 | 379.74% |
| Dec 31, 2020 | 22.20% |
| Sep 30, 2020 | 292.62% |
| Mar 31, 2020 | -75.73% |
| Dec 31, 2019 | 110.50% |
| Sep 30, 2019 | -11.46% |
| Mar 31, 2019 | 107.63% |
| Dec 31, 2018 | -47.75% |